Shufeng Weng

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Escherichia Coli

Immune Response

Top Venues

Phenomics (Cham, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Shufeng Weng, Qingchun Li, Tianran Zhang, Taiyue Lin, Yumo He, Guang Yang, Honghai Wang, Ying Xu
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. Vaccines 12 (6) (2024)
Shufeng Weng, Qingchun Li, Tianran Zhang, Taiyue Lin, Yumo He, Guang Yang, Honghai Wang, Ying Xu
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. Vaccines 12 (6) (2024)
Shufeng Weng, Qingchun Li, Tianran Zhang, Taiyue Lin, Yumo He, Guang Yang, Honghai Wang, Ying Xu
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. Vaccines 12 (6) (2024)
Zhenyu Zhu, Shufeng Weng, Fen Zheng, Qi Zhao, Ying Xu, Jiaxue Wu
Identification of Poly(ADP-ribose) Polymerase 9 (PARP9) as a Potent Suppressor for Mycobacterium tuberculosis Infection. Phenomics (Cham, Switzerland) 4 (2) (2023)
Zhenyu Zhu, Shufeng Weng, Fen Zheng, Qi Zhao, Ying Xu, Jiaxue Wu
Identification of Poly(ADP-ribose) Polymerase 9 (PARP9) as a Potent Suppressor for Mycobacterium tuberculosis Infection. Phenomics (Cham, Switzerland) 4 (2) (2023)